Skip to content
S2710Senate2011-2012 SessionSame asA9311

Establishes the biosciences commercialization assistance fund within the foundation for science, technology and innovation

Sponsor Mark GrisantiSD-60+3 co-sponsorsAffects Finance
Status
In Senate Committee
Finance
Impact
Pending
Passage
Pending

Bill progress

Step 2 of 7

In committee · Finance

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

Primary sponsor
Mark Grisanti

Senator · Senate District 60

Chair, Environmental Conservation

History

  1. Reported and committed to finance
  2. Referred to commerce, economic development and small business
  3. Referred to commerce, economic development and small business

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9311Assembly

Establishes the biosciences commercialization assistance fund within the foundation for science, technology and innovation

In Assembly Committee · Economic Development · Sponsor Sean Ryan

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

BILL NUMBER:S2710

Title of bill

An act to amend the public authorities law, in relation to establishing the biosciences commercialization assistance fund within the foundation for science, technology and innovation

Purpose or general idea of bill

This bill would create a new program within the foundation for science, technology and innovation to aid the commercialization of bioscience innovations through grants and assistance to companies and research institutions.

Summary of specific provisions

Section 1 amends section 3150 of the public authorities law by defining "research entity"and "focus area," Section 2 adds a new section 3154-a to a new biosciences commercialization assistance and defines the purposes and uses of the fund. The foundation must give priority to projects that have the greatest chance of commercial success. Section 3 makes available funds from the incentive program part of the research development program. Section 4 establishes the effectiveness date.

Justification

Bioscience-based industries such as those manufacturing medical devices hold an important place in clusters of the knowledge based economy in New York State. In roundtable discussions hosted by the Task Force on University-Industry Cooperation and the Commission on Science and Technology, participants called for new legislative initiatives that benefit the biosciences industry. It was noted that the biosciences are and are likely to continue to be very important in New York State, and that New York continues to be a leader in attracting research for biosciences research. The need for a set of commercialization incentives that targets biosciences is highlighted by the fact that commercialization of bioscience innovations can often extend to ten or fifteen years reflecting in part the requirement of extensive clinical trials.

Prior legislative history

S.2290 of 2009-10; Reported to Finance

Fiscal implications

The new fund will depend upon the allocation of available appropriations

Effective date

The act would take effect in 180 days.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.